engleski

Reporting Vaginal Dose Point in Cervical Cancer Patients Treated with Combined EBRT and HDR Brachytherapy

Cervical cancer patients with locally advanced disease are treated with combined external beam radiotherapy EBRT and high dose rate brachytherapy HDRBT. In treatment reports, doses to HRCTV (high risk clinical target volume) and doses for organs at risk, bladder and rectum, are usually reported. Dose constraints for vagina as organ at risk and methods for reporting vaginal dose points are not yet introduced in clinical practice. This study aims to analyze and report vaginal dose points in the lower and upper part of vagina.

HDR brachytherapy; cervical cancer; vaginal dose

nije evidentirano